1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

coenzyme Q10A ; Mus musculus







16 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32724177 Autophagy-dependent removal of α-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson's disease. 2021 Apr 1
2 24821093 GM1 ganglioside enhances Ret signaling in striatum. 2014 Aug 1
3 7796105 Enhanced restoration of striatal dopamine concentrations by combined GM1 ganglioside and neurotrophic factor treatments. 1995 Mar 20 1
4 8164837 Oral administration of semisynthetic sphingolipids promotes recovery of striatal dopamine concentrations in a murine model of parkinsonism. 1994 Apr 2
5 1899692 Preproenkephalin mRNA and methionine-enkephalin increase in mouse striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment. 1991 Mar 1
6 2076347 [Recovery of nigrostriatal and mesolimbic dopaminergic system following administration of ganglioside in MPTP-treated mice]. 1990 Nov 2
7 2250172 GM1 gangliosides alter acute MPTP-induced behavioral and neurochemical toxicity in mice. 1990 Oct 4
8 2532603 Treatment with GM1 ganglioside reverses dopamine D-2 receptor supersensitivity induced by the neurotoxin MPTP. 1989 Sep 13 1
9 2532697 Continued administration of GM1 ganglioside is required to maintain recovery from neuroleptic-induced sensorimotor deficits in MPTP-treated mice. 1989 2
10 2565752 GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study. 1989 Apr 10 2
11 2568945 GM1 ganglioside treatment promotes recovery of striatal dopamine concentrations in the mouse model of MPTP-induced parkinsonism. 1989 Aug 8
12 2601883 Exogenous GM1 gangliosides induce partial recovery of the nigrostriatal dopaminergic system in MPTP-treated young mice but not in aging mice. 1989 Dec 4 3
13 2903475 Administration of GM1 ganglioside eliminates neuroleptic-induced sensorimotor deficits in MPTP-treated mice. 1988 Oct 5 2
14 3262149 Treatment with GM1 ganglioside restores striatal dopamine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse. 1988 Oct 3
15 3265839 GM1 ganglioside protects against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse. 1988 Apr 1
16 3490632 Administration of GM1 ganglioside restores the dopamine content in striatum after chronic treatment with MPTP. 1986 Sep 1